FINWIRES · TerminalLIVE
FINWIRES

Recce Pharmaceuticals to Raise AU$4 million via Share Placement; Shares Down 17%

By

Recce Pharmaceuticals (ASX:RCE) received firm commitments to raise AU$4 million through the placement of 10 million new shares at AU$0.40 apiece, according to a Friday filing with the Australian bourse.

The company is also launching a share purchase plan to allow eligible shareholders to subscribe for up to AU$30,000 worth of new shares to raise up to a further AU$4 million on the same terms as the placement, the filing said.

Funds will be used to bolster the balance sheet for commercial licensing with a Middle Eastern pharmaceutical firm, and fund clinical trials and Investigational New Drug enabling activities, per the filing.

Shares fell 17% in morning trade on Friday.

Related Articles

Asia

Lopal Tech Says No Undisclosed Matters That Would Warrant Unusual Movement in Stock Price

Jiangsu Lopal Tech. Group (SHA:603906, HKG:2465) said there were no undisclosed matters that would warrant an unusual movement in its stock's price, according to a Hong Kong bourse filing Wednesday.Shares of the automotive specialty chemicals seller were down nearly 6% in Thursday late morning trade.On Wednesday, its shares rose 2% at close, snapping a three-day streak of losses.

HKG:2465SHA:603906
Asia

Hong Kong's H1 IPO Proceeds Hit Five-Year High, EY Says

Ernst & Young expects 84 initial public offerings in Hong Kong during the first half of 2026, raising a combined HK$209.8 billion, a five-year high, the audit firm said in its Chinese mainland and Hong Kong IPO report released Wednesday.The company noted a 100% increase in the number of IPOs and a 92% jump in funds raised in H1 2026 from the same period last year.A-share firms remained a key driver of the Hong Kong IPO market, with 121 mainland-listed companies applying for Hong Kong listings as of June 23.Industrial and technology companies accounted for 65% of IPO deals and 74% of total proceeds. These sectors mostly comprise segments such as AI large models and semiconductor chips, according to the report.

Hang Seng
Asia

Samsung Electronics Denies Rumors of KRW90 Trillion Share Buyback Plan; Shares Rise 5%

Samsung Electronics (KRX:005930) denied media rumors of the company planning to repurchase 90 trillion won worth of shares over a period of three years, beginning in July, according to a Thursday filing with the Korea Exchange.Denying the report published by Munhwa Ilbo in a Wednesday news report, Samsung Electronics said that although it was reviewing a share repurchase plan for stock-based compensation based on its 2026 management performance, no key matters, including the schedule or scale of the repurchase, had been finalized.Shares of the company rose nearly 5% in recent trade.

KRX:005930